vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.

Sezzle Inc. is the larger business by last-quarter revenue ($78.2M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). Sezzle Inc. runs the higher net margin — 54.6% vs -19.9%, a 74.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 61.6%). Sezzle Inc. produced more free cash flow last quarter ($70.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 76.0%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.

ABCL vs SEZL — Head-to-Head

Bigger by revenue
SEZL
SEZL
1.7× larger
SEZL
$78.2M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+726.8% gap
ABCL
788.4%
61.6%
SEZL
Higher net margin
SEZL
SEZL
74.5% more per $
SEZL
54.6%
-19.9%
ABCL
More free cash flow
SEZL
SEZL
$115.2M more FCF
SEZL
$70.6M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
76.0%
SEZL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
SEZL
SEZL
Revenue
$44.9M
$78.2M
Net Profit
$-8.9M
$42.7M
Gross Margin
Operating Margin
-63.7%
70.6%
Net Margin
-19.9%
54.6%
Revenue YoY
788.4%
61.6%
Net Profit YoY
73.9%
68.3%
EPS (diluted)
$-0.03
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
SEZL
SEZL
Q4 25
$44.9M
$78.2M
Q3 25
$9.0M
$57.5M
Q2 25
$17.1M
$52.0M
Q1 25
$4.2M
$48.2M
Q4 24
$5.0M
$48.4M
Q3 24
$6.5M
$35.6M
Q2 24
$7.3M
$30.2M
Q1 24
$10.0M
$25.2M
Net Profit
ABCL
ABCL
SEZL
SEZL
Q4 25
$-8.9M
$42.7M
Q3 25
$-57.1M
$26.7M
Q2 25
$-34.7M
$27.6M
Q1 25
$-45.6M
$36.2M
Q4 24
$25.4M
Q3 24
$-51.1M
$15.4M
Q2 24
$-36.9M
$29.7M
Q1 24
$-40.6M
$8.0M
Operating Margin
ABCL
ABCL
SEZL
SEZL
Q4 25
-63.7%
70.6%
Q3 25
-851.8%
61.9%
Q2 25
-290.2%
69.4%
Q1 25
-1479.6%
Q4 24
63.8%
Q3 24
-1439.4%
58.6%
Q2 24
-1276.2%
55.3%
Q1 24
-551.5%
54.8%
Net Margin
ABCL
ABCL
SEZL
SEZL
Q4 25
-19.9%
54.6%
Q3 25
-637.8%
46.4%
Q2 25
-203.3%
53.1%
Q1 25
-1077.2%
75.1%
Q4 24
52.4%
Q3 24
-785.4%
43.4%
Q2 24
-504.3%
98.4%
Q1 24
-408.0%
31.7%
EPS (diluted)
ABCL
ABCL
SEZL
SEZL
Q4 25
$-0.03
$1.19
Q3 25
$-0.19
$0.75
Q2 25
$-0.12
$0.78
Q1 25
$-0.15
$1.00
Q4 24
$0.71
Q3 24
$-0.17
$0.44
Q2 24
$-0.13
$0.82
Q1 24
$-0.14
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
SEZL
SEZL
Cash + ST InvestmentsLiquidity on hand
$128.5M
$64.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$169.8M
Total Assets
$1.4B
$400.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
SEZL
SEZL
Q4 25
$128.5M
$64.1M
Q3 25
$83.2M
$104.1M
Q2 25
$92.4M
$88.9M
Q1 25
$159.3M
$88.9M
Q4 24
$156.3M
$73.2M
Q3 24
$126.6M
$80.1M
Q2 24
$148.3M
$58.0M
Q1 24
$123.6M
$77.8M
Stockholders' Equity
ABCL
ABCL
SEZL
SEZL
Q4 25
$966.9M
$169.8M
Q3 25
$964.0M
$155.3M
Q2 25
$1.0B
$130.4M
Q1 25
$1.0B
$125.8M
Q4 24
$1.1B
$87.8M
Q3 24
$1.1B
$61.1M
Q2 24
$1.1B
$50.3M
Q1 24
$1.1B
$29.6M
Total Assets
ABCL
ABCL
SEZL
SEZL
Q4 25
$1.4B
$400.2M
Q3 25
$1.4B
$367.0M
Q2 25
$1.4B
$350.6M
Q1 25
$1.3B
$298.1M
Q4 24
$1.4B
$298.4M
Q3 24
$1.4B
$252.9M
Q2 24
$1.4B
$212.1M
Q1 24
$1.5B
$195.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
SEZL
SEZL
Operating Cash FlowLast quarter
$-34.7M
$70.6M
Free Cash FlowOCF − Capex
$-44.6M
$70.6M
FCF MarginFCF / Revenue
-99.4%
90.2%
Capex IntensityCapex / Revenue
21.9%
0.1%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$209.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
SEZL
SEZL
Q4 25
$-34.7M
$70.6M
Q3 25
$-52.6M
$63.7M
Q2 25
$-32.4M
$23.1M
Q1 25
$-11.6M
$52.5M
Q4 24
$-108.6M
$57.4M
Q3 24
$-28.9M
$35.1M
Q2 24
$-30.0M
$22.2M
Q1 24
$-41.7M
$16.0M
Free Cash Flow
ABCL
ABCL
SEZL
SEZL
Q4 25
$-44.6M
$70.6M
Q3 25
$-61.5M
$63.6M
Q2 25
$-45.8M
$22.7M
Q1 25
$-22.2M
$52.5M
Q4 24
$-187.0M
$57.4M
Q3 24
$-47.4M
$35.1M
Q2 24
$-50.1M
$22.2M
Q1 24
$-65.8M
$16.0M
FCF Margin
ABCL
ABCL
SEZL
SEZL
Q4 25
-99.4%
90.2%
Q3 25
-687.0%
110.6%
Q2 25
-267.9%
43.6%
Q1 25
-524.0%
108.9%
Q4 24
-3702.8%
118.5%
Q3 24
-728.4%
98.6%
Q2 24
-683.8%
73.4%
Q1 24
-661.5%
63.3%
Capex Intensity
ABCL
ABCL
SEZL
SEZL
Q4 25
21.9%
0.1%
Q3 25
99.7%
0.3%
Q2 25
78.2%
0.8%
Q1 25
251.1%
0.1%
Q4 24
1552.7%
0.1%
Q3 24
284.6%
0.0%
Q2 24
274.6%
0.1%
Q1 24
242.5%
0.0%
Cash Conversion
ABCL
ABCL
SEZL
SEZL
Q4 25
1.65×
Q3 25
2.39×
Q2 25
0.84×
Q1 25
1.45×
Q4 24
2.26×
Q3 24
2.27×
Q2 24
0.75×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

SEZL
SEZL

Merchant And Partner Income$28.9M37%
Transaction Income$25.9M33%
Income From Other Services Late Payment Fees$20.5M26%
Other$2.9M4%

Related Comparisons